Northwest Biotherapeutics (NWBO) FCF Margin (QoQ) (2013 - 2026)
Northwest Biotherapeutics (NWBO) FCF Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Northwest Biotherapeutics | 253,653.43 | -1.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,660.00 |
| Dec 31, 2025 | 471,580.00 |
| Sep 30, 2025 | -171,010.00 |
| Jun 30, 2025 | -280,114.00 |
| Mar 31, 2025 | 623,386.00 |
| Dec 31, 2024 | -641,467.00 |
| Sep 30, 2024 | 92,258.00 |
| Jun 30, 2024 | 117,443.00 |
| Mar 31, 2024 | -54,775.00 |
| Dec 31, 2023 | -36,876.00 |
| Sep 30, 2023 | 281,727.00 |
| Jun 30, 2023 | -492,460.00 |
| Mar 31, 2023 | 41,542.00 |
| Dec 31, 2022 | 611,420.00 |
| Sep 30, 2022 | -476,140.00 |
| Jun 30, 2022 | 3,515.00 |
| Sep 30, 2021 | -77,762.00 |
| Jun 30, 2021 | 365,860.00 |
| Mar 31, 2021 | -301,638.00 |
| Dec 31, 2020 | 211,467.00 |